State Street Corp Provention Bio, Inc. Transaction History

State Street Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.7 - $24.21 $1.17 Million - $4.22 Million	174,268 Added 11.18%	1,732,506 $41.8 Million
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $1.19 Million - $2.79 Million	263,813 Added 20.38%	1,558,238 $16.5 Million
Q3 2022 Nov 15, 2022	BUY	$3.43 - $5.62 $292,359 - $479,026	85,236 Added 7.05%	1,294,425 $5.83 Million
Q2 2022 Aug 15, 2022	SELL	$3.65 - $7.3 $238,991 - $477,982	-65,477 Reduced 5.14%	1,209,189 $4.84 Million
Q1 2022 May 16, 2022	BUY	$3.4 - $7.88 $210,650 - $488,213	61,956 Added 5.11%	1,274,666 $9.33 Million
Q4 2021 Feb 14, 2022	SELL	$5.59 - $7.39 $1.19 Million - $1.57 Million	-213,028 Reduced 14.94%	1,212,710 $6.82 Million
Q3 2021 Nov 15, 2021	BUY	$5.66 - $8.33 $551,289 - $811,350	97,401 Added 7.33%	1,425,738 $9.13 Million
Q2 2021 Aug 16, 2021	BUY	$6.71 - $11.04 $1.63 Million - $2.68 Million	242,728 Added 22.36%	1,328,337 $11.2 Million
Q1 2021 May 17, 2021	BUY	$10.12 - $19.45 $907,197 - $1.74 Million	89,644 Added 9.0%	1,085,609 $11.4 Million
Q4 2020 Feb 16, 2021	SELL	$11.79 - $18.94 $439,460 - $705,969	-37,274 Reduced 3.61%	995,965 $16.9 Million
Q3 2020 Nov 10, 2020	BUY	$10.34 - $15.2 $1.73 Million - $2.55 Million	167,640 Added 19.37%	1,033,239 $13.3 Million
Q2 2020 Aug 14, 2020	BUY	$7.81 - $17.0 $6.61 Million - $14.4 Million	846,499 Added 4431.93%	865,599 $12.2 Million
Q1 2020 May 11, 2020	BUY	$5.42 - $17.75 $103,522 - $339,025	19,100 New	19,100 $176,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.